Bionano Genomics, Inc. (BNGO)

Bionano Genomics, Inc. in the Healthcare sector is trading at $1.39 with a market capitalization of $16M. Wall Street consensus targets $5.00 (2 analysts), implying a +259.7% move over the next 12 months. The stock is currently 38% below its 52-week high of $2.23, remaining 10.3% above its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the distress zone. Risk note: RSI 23 is oversold, raising the odds of a near-term bounce. The Whystock Score of 75/100 reflects bullish alignment across trend, valuation and analyst targets.